Clinical Trial Update: Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating unilateral nerve-sparing cryoablation for low-risk, clinically localized unilateral prostate cancer has been terminated. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cryoablation

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED